Thomas Charles Heineman, Chief Officer of Oncolytics Biotech ONCY, has filed 1 purchase and 0 sales on the open market. Over the past 12 months that comes to a net purchase of $10.1K. The latest trade was on 06/01.

TH

TH

Thomas Charles Heineman

Chief Medical Officer

Company

Oncolytics Biotech ONCY

First filing

26/02/13

Trades

2 trades

Buys / sales

1 / 0

12-month net buying

$10.1K

Last trade

06/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Oncolytics BiotechONCY	Open-market buy	02/12	02/13	12,132 sh	$0.83	$10,069.56	+4.5%